{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:11Z","timestamp":1761896471498},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Shanghai Municipal Education Commission\u2014Gaofeng Clinical Medicine Grant Support","award":["20161430"],"award-info":[{"award-number":["20161430"]}]},{"name":"Shanghai Municipal Science and Technology Commission Medical Guide Project","award":["15411963500"],"award-info":[{"award-number":["15411963500"]}]},{"name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region of China","award":["2016D01C084"],"award-info":[{"award-number":["2016D01C084"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00592-017-0968-z","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T05:26:41Z","timestamp":1487222801000},"page":"463-470","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status"],"prefix":"10.1007","volume":"54","author":[{"given":"Hang","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"968_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-800263-6.00007-0","volume":"64","author":"M Koga","year":"2014","unstructured":"Koga M (2014) 1,5-Anhydroglucitol and glycated albumin in glycemia. Adv Clin Chem 64:269\u2013301","journal-title":"Adv Clin Chem"},{"issue":"5","key":"968_CR2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/dia.2014.0346","volume":"17","author":"X Ma","year":"2015","unstructured":"Ma X, Hao Y, Hu X et al (2015) 1,5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus. Diabetes Technol Ther 17(5):320\u2013326","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"968_CR3","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/diacare.27.8.1859","volume":"27","author":"JB McGill","year":"2004","unstructured":"McGill JB, Cole TG, Nowatzke W et al (2004) Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care 27(8):1859\u20131865","journal-title":"Diabetes Care"},{"issue":"3","key":"968_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clinbiochem.2008.08.086","volume":"42","author":"CL Nerby","year":"2009","unstructured":"Nerby CL, Stickle DF (2009) 1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective. Clin Biochem 42(3):158\u2013167","journal-title":"Clin Biochem"},{"issue":"8","key":"968_CR5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2337\/dc08-0385","volume":"31","author":"C Stettler","year":"2008","unstructured":"Stettler C, Stahl M, Allemann S et al (2008) Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 31(8):1534\u20131535","journal-title":"Diabetes Care"},{"issue":"6","key":"968_CR6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/dc06-1910","volume":"29","author":"KM Dungan","year":"2006","unstructured":"Dungan KM, Buse JB, Largay J et al (2006) 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29(6):1214\u20131219","journal-title":"Diabetes Care"},{"issue":"4","key":"968_CR7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00592-011-0302-0","volume":"50","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Jung HS, Hwang-Bo Y et al (2013) Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol 50(4):505\u2013510","journal-title":"Acta Diabetol"},{"issue":"1","key":"968_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-012-9760-6","volume":"43","author":"WJ Kim","year":"2013","unstructured":"Kim WJ, Park CY (2013) 1,5-Anhydroglucitol in diabetes mellitus. Endocrine 43(1):33\u201340","journal-title":"Endocrine"},{"issue":"1","key":"968_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-4165(96)00050-5","volume":"1291","author":"T Yamanouchi","year":"1996","unstructured":"Yamanouchi T, Shinohara T, Ogata N, Tachibana Y, Akaoka I, Miyashita H (1996) Common reabsorption system of 1,5-anhydro-d-glucitol, fructose, and mannose in rat renal tubule. Biochim Biophys Acta 1291(1):89\u201395","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"968_CR10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/BF00277486","volume":"31","author":"Y Akanuma","year":"1988","unstructured":"Akanuma Y, Morita M, Fukuzawa N, Yamanouchi T, Akanuma H (1988) Urinary excretion of 1,5-anhydro-d-glucitol accompanying glucose excretion in diabetic patients. Diabetologia 31(11):831\u2013835","journal-title":"Diabetologia"},{"issue":"1","key":"968_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1507\/endocrj.K10E-224","volume":"58","author":"M Goto","year":"2011","unstructured":"Goto M, Yamamoto-Honda R, Shimbo T et al (2011) Correlation between baseline serum 1,5-anhydroglucitol levels and 2-h post-challenge glucose levels during oral glucose tolerance tests. Endocr J 58(1):13\u201317","journal-title":"Endocr J"},{"key":"968_CR12","volume-title":"Report of a WHO Consultation: definition, diagnosis and classification of diabetes mellitus and its complication: Part1: diagnosis and classification of diabetes mellitus","author":"Department of Noncommunicable Disease Surveillance","year":"1999","unstructured":"Department of Noncommunicable Disease Surveillance (1999) Report of a WHO Consultation: definition, diagnosis and classification of diabetes mellitus and its complication: Part1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva"},{"key":"968_CR13","first-page":"1","volume":"894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1\u2013253","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"4","key":"968_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00125-013-2830-3","volume":"56","author":"N Nowak","year":"2013","unstructured":"Nowak N, Skupien J, Cyganek K, Matejko B, Malecki MT (2013) 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia 56(4):709\u2013713","journal-title":"Diabetologia"},{"key":"968_CR15","doi-asserted-by":"crossref","unstructured":"Wang Y, Yuan Y, Zhang Y et al (2016) Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes. Acta Diabetol Nov 28 [Epub ahead of print]","DOI":"10.1007\/s00592-016-0944-z"},{"issue":"22","key":"968_CR16","first-page":"3641","volume":"124","author":"J Sun","year":"2011","unstructured":"Sun J, Dou JT, Wang XL et al (2011) Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients. Chin Med J (Engl) 124(22):3641\u20133645","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"968_CR17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4103\/2230-8210.190559","volume":"20","author":"TA Pramodkumar","year":"2016","unstructured":"Pramodkumar TA, Jayashri R, Gokulakrishnan K et al (2016) Relationship of glycemic control markers\u20141,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance. Indian J Endocrinol Metab 20(5):690\u2013695","journal-title":"Indian J Endocrinol Metab"},{"key":"968_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-014-0166-z","volume":"14","author":"X Ma","year":"2015","unstructured":"Ma X, Hu X, Zhou J et al (2015) Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c. Cardiovasc Diabetol 14:16","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"968_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/db15-0607","volume":"65","author":"E Selvin","year":"2016","unstructured":"Selvin E, Rawlings A, Lutsey P et al (2016) Association of 1,5-Anhydroglucitol with cardiovascular disease and mortality. Diabetes 65(1):201\u2013208","journal-title":"Diabetes"},{"issue":"9","key":"968_CR20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1464-5491.2012.03613.x","volume":"29","author":"WJ Kim","year":"2012","unstructured":"Kim WJ, Park CY, Park SE et al (2012) Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes. Diabet Med 29(9):1184\u20131190","journal-title":"Diabet Med"},{"issue":"2","key":"968_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2011.02.033","volume":"216","author":"M Watanabe","year":"2011","unstructured":"Watanabe M, Kokubo Y, Higashiyama A, Ono Y, Miyamoto Y, Okamura T (2011) Serum 1,5-anhydro-d-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study. Atherosclerosis 216(2):477\u2013483","journal-title":"Atherosclerosis"},{"issue":"6","key":"968_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1536\/ihj.15-177","volume":"56","author":"N Ikeda","year":"2015","unstructured":"Ikeda N, Hara H, Hiroi Y (2015) Ability of 1,5-anhydro-d-glucitol values to predict coronary artery disease in a non-diabetic population. Int Heart J 56(6):587\u2013591","journal-title":"Int Heart J"},{"issue":"4","key":"968_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jjcc.2014.02.014","volume":"64","author":"N Ikeda","year":"2014","unstructured":"Ikeda N, Hara H, Hiroi Y (2014) 1,5-Anhydro-d-glucitol predicts coronary artery disease prevalence and complexity. J Cardiol 64(4):297\u2013301","journal-title":"J Cardiol"},{"issue":"4","key":"968_CR24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00380-014-0502-y","volume":"30","author":"T Fujiwara","year":"2015","unstructured":"Fujiwara T, Yoshida M, Yamada H et al (2015) Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk. Heart Vessels 30(4):469\u2013476","journal-title":"Heart Vessels"},{"issue":"1","key":"968_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-016-0459-5","volume":"15","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Shimada K, Miyauchi K et al (2016) Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention. Cardiovasc Diabetol 15(1):145","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"968_CR26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/jf304683s","volume":"61","author":"A Kato","year":"2013","unstructured":"Kato A, Kunimatsu T, Yamashita Y, Adachi I, Takeshita K, Ishikawa F (2013) Protective effects of dietary 1,5-anhydro-d-glucitol as a blood glucose regulator in diabetes and metabolic syndrome. J Agric Food Chem 61(3):611\u2013617","journal-title":"J Agric Food Chem"},{"issue":"2\u20133","key":"968_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0304-4165(03)00160-0","volume":"1623","author":"T Yamanouchi","year":"2003","unstructured":"Yamanouchi T, Inoue T, Ichiyanagi K, Sakai T, Ogata N (2003) 1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines. Biochim Biophys Acta 1623(2\u20133):82\u201387","journal-title":"Biochim Biophys Acta"},{"issue":"4 Pt 1","key":"968_CR28","first-page":"E821","volume":"273","author":"D Stickle","year":"1997","unstructured":"Stickle D, Turk J (1997) A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol 273(4 Pt 1):E821\u2013E830","journal-title":"Am J Physiol"},{"issue":"3 Pt 1","key":"968_CR29","first-page":"E423","volume":"258","author":"T Yamanouchi","year":"1990","unstructured":"Yamanouchi T, Akaoka I, Akanuma Y, Akanuma H, Miyashita E (1990) Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents. Am J Physiol 258(3 Pt 1):E423\u2013E427","journal-title":"Am J Physiol"},{"issue":"2","key":"968_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/diab.35.2.204","volume":"35","author":"T Yamanouchi","year":"1986","unstructured":"Yamanouchi T, Akanuma H, Takaku F, Akanuma Y (1986) Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment. Diabetes 35(2):204\u2013209","journal-title":"Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-0968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-017-0968-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-0968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T06:45:55Z","timestamp":1658645155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-017-0968-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1007\/s00592-017-0968-z","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}